Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 11 | 2018 | 1502 | 1.250 |
Why?
|
| Estrogen Receptor alpha | 6 | 2015 | 111 | 1.200 |
Why?
|
| Metformin | 2 | 2018 | 65 | 1.020 |
Why?
|
| Cell Movement | 4 | 2018 | 571 | 0.640 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 104 | 0.630 |
Why?
|
| Antioxidants | 1 | 2018 | 416 | 0.510 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 128 | 0.500 |
Why?
|
| Casein Kinase II | 2 | 2015 | 15 | 0.490 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 803 | 0.460 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2013 | 3 | 0.450 |
Why?
|
| Cell Line, Tumor | 9 | 2018 | 2231 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2013 | 807 | 0.340 |
Why?
|
| Gene Products, tat | 2 | 2005 | 35 | 0.330 |
Why?
|
| Milk Proteins | 2 | 2005 | 29 | 0.310 |
Why?
|
| Trans-Activators | 2 | 2005 | 174 | 0.290 |
Why?
|
| Megakaryocytes | 1 | 2005 | 7 | 0.270 |
Why?
|
| CREB-Binding Protein | 1 | 2005 | 13 | 0.270 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 54 | 0.260 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 59 | 0.250 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 61 | 0.240 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 539 | 0.240 |
Why?
|
| Nitriles | 2 | 2015 | 69 | 0.240 |
Why?
|
| Triazoles | 2 | 2015 | 86 | 0.230 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 1015 | 0.230 |
Why?
|
| Cell Differentiation | 2 | 2005 | 587 | 0.220 |
Why?
|
| HIV-1 | 2 | 2005 | 706 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2015 | 222 | 0.210 |
Why?
|
| Phosphorylation | 7 | 2012 | 928 | 0.210 |
Why?
|
| Female | 12 | 2018 | 20969 | 0.190 |
Why?
|
| Humans | 16 | 2018 | 37093 | 0.180 |
Why?
|
| Dinoprostone | 1 | 2018 | 63 | 0.160 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2018 | 56 | 0.160 |
Why?
|
| Serine | 2 | 2011 | 75 | 0.160 |
Why?
|
| Disease-Free Survival | 2 | 2015 | 113 | 0.150 |
Why?
|
| Pterocarpans | 1 | 2015 | 21 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 461 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 515 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2018 | 1198 | 0.130 |
Why?
|
| Transcription, Genetic | 3 | 2011 | 578 | 0.130 |
Why?
|
| Estrogens | 2 | 2013 | 202 | 0.120 |
Why?
|
| Data Mining | 1 | 2013 | 23 | 0.110 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 90 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2013 | 77 | 0.110 |
Why?
|
| Gene Silencing | 1 | 2013 | 151 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 142 | 0.100 |
Why?
|
| Breast | 1 | 2013 | 135 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 172 | 0.100 |
Why?
|
| HIV Infections | 1 | 2005 | 2303 | 0.100 |
Why?
|
| Proteomics | 1 | 2013 | 325 | 0.090 |
Why?
|
| Organogenesis | 1 | 2010 | 16 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 172 | 0.090 |
Why?
|
| Prognosis | 1 | 2013 | 739 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 59 | 0.090 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2010 | 40 | 0.090 |
Why?
|
| Antibodies, Phospho-Specific | 1 | 2009 | 1 | 0.090 |
Why?
|
| COS Cells | 1 | 2009 | 69 | 0.090 |
Why?
|
| Response Elements | 2 | 2010 | 56 | 0.090 |
Why?
|
| Gene Expression | 1 | 2013 | 674 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2010 | 78 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 132 | 0.090 |
Why?
|
| Protein Binding | 3 | 2011 | 972 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 188 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 626 | 0.080 |
Why?
|
| K562 Cells | 2 | 2005 | 32 | 0.080 |
Why?
|
| Animals | 5 | 2015 | 15081 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2005 | 41 | 0.080 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2008 | 12 | 0.080 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 2005 | 53 | 0.080 |
Why?
|
| Antibody Specificity | 1 | 2008 | 79 | 0.080 |
Why?
|
| Hela Cells | 1 | 2009 | 366 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2009 | 130 | 0.080 |
Why?
|
| Antibodies | 1 | 2008 | 141 | 0.080 |
Why?
|
| Transfection | 2 | 2010 | 523 | 0.080 |
Why?
|
| STAT5 Transcription Factor | 2 | 2005 | 46 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1371 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2013 | 1908 | 0.080 |
Why?
|
| Mice | 3 | 2015 | 5913 | 0.070 |
Why?
|
| Integrin beta3 | 1 | 2005 | 6 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 43 | 0.070 |
Why?
|
| Mutation | 1 | 2010 | 1095 | 0.070 |
Why?
|
| Receptors, CCR5 | 1 | 2005 | 61 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2006 | 156 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 1180 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2005 | 69 | 0.060 |
Why?
|
| Carcinogens | 1 | 2005 | 124 | 0.060 |
Why?
|
| Caseins | 1 | 2004 | 13 | 0.060 |
Why?
|
| Nuclear Localization Signals | 1 | 2004 | 17 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2004 | 23 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2005 | 513 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 194 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1039 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2010 | 366 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2015 | 337 | 0.030 |
Why?
|
| DNA Primers | 2 | 2005 | 286 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 893 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 623 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 35 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 31 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 30 | 0.030 |
Why?
|
| Vimentin | 1 | 2013 | 37 | 0.030 |
Why?
|
| Base Sequence | 2 | 2005 | 997 | 0.030 |
Why?
|
| Mesoderm | 1 | 2013 | 70 | 0.030 |
Why?
|
| Amides | 1 | 2013 | 68 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 122 | 0.030 |
Why?
|
| Pyridines | 1 | 2013 | 116 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 251 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2011 | 5 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 213 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2011 | 43 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 91 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 859 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 681 | 0.020 |
Why?
|
| Gonads | 1 | 2010 | 20 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2010 | 59 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 245 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2010 | 99 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 409 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 208 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 252 | 0.020 |
Why?
|
| Estradiol | 1 | 2011 | 262 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2008 | 67 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2008 | 56 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 651 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 164 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 1354 | 0.020 |
Why?
|
| DNA | 1 | 2010 | 574 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2006 | 17 | 0.020 |
Why?
|
| Butyric Acid | 1 | 2005 | 18 | 0.020 |
Why?
|
| Cell Division | 1 | 2006 | 307 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2005 | 26 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 53 | 0.020 |
Why?
|
| Chromatin | 1 | 2006 | 169 | 0.020 |
Why?
|
| Serotonin | 1 | 2005 | 123 | 0.020 |
Why?
|
| Homeostasis | 1 | 2006 | 188 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2005 | 399 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 381 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 260 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 421 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 1568 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 1549 | 0.010 |
Why?
|